TREM2 agonist monoclonal antibody

This page covers all TREM2 agonist monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting TREM2.

Targets

TREM2

Phase 3 pipeline (1)

• AL001 · Alector Inc. · Neurology
  AL001 is a monoclonal antibody that activates TREM2 signaling on microglia to promote neuroinflammatory resolution and clearance of pathogenic proteins in neurodegenerative disease.